GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Capital Expenditures came in at $100.0 million in Q2 2026, up 16.28% YoY from $86.0 million in Q2 2025, and down 43.82% on a QoQ basis from $178.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Capital Expenditures data on file, last reported at $100.0 million in Q2 2026.
- Quarterly Capital Expenditures rose 16.28% year-over-year to $100.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $522.0 million (up 21.4% YoY) and the FY2025 annual result came in at $482.0 million, up 20.2% from the prior year.
- Capital Expenditures fell to $100.0 million in Q2 2026, from $178.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $178.0 million in Q1 2026 to a low of $59.0 million in Q2 2022.
- A 5-year average of $103.2 million and a median of $97.0 million in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures surged 43.0% — and 2024, when it dropped 8.57%.
- Tracing GEHC's Capital Expenditures over 5 years: stood at $77.0 million in 2022, then rose by 22.08% to $94.0 million in 2023, then grew by 8.51% to $102.0 million in 2024, then soared by 31.37% to $134.0 million in 2025, then fell by 25.37% to $100.0 million in 2026.
- The last three Capital Expenditures figures came in at $100.0 million (Q2 2026), $178.0 million (Q1 2026), and $134.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.00 Mn |
| Jun 30, 2026 | 100.00 Mn |
| Mar 31, 2026 | 178.00 Mn |
| Mar 31, 2026 | 178.00 Mn |
| Dec 31, 2025 | 134.00 Mn |
| Dec 31, 2025 | 134.00 Mn |
| Sep 30, 2025 | 110.00 Mn |
| Sep 30, 2025 | 110.00 Mn |
| Jun 30, 2025 | 86.00 Mn |
| Jun 30, 2025 | 86.00 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Dec 31, 2024 | 102.00 Mn |
| Dec 31, 2024 | 102.00 Mn |
| Sep 30, 2024 | 90.00 Mn |
| Sep 30, 2024 | 90.00 Mn |
| Jun 30, 2024 | 64.00 Mn |
| Jun 30, 2024 | 64.00 Mn |
| Mar 31, 2024 | 145.00 Mn |
| Mar 31, 2024 | 145.00 Mn |